Search For a Provider Facebook Twitter Instagram YouTube ES Contact Us

News

Men on Androgen Deprivation Therapy May Be at Higher Risk for Alzheimer’s

Jan 18, 2016

Men on Androgen Deprivation Therapy May Be at Higher Risk for Alzheimer’sMen on androgen deprivation therapy (ADT), a treatment for prostate cancer, might be at increased risk for Alzheimer’s disease, American researchers report.

The findings do not mean that ADT causes Alzheimer’s. However, the scientists have found an association that warrants further research.

Androgens, such as testosterone, are often considered male hormones because they are important for masculine traits. (Women’s bodies make androgens, too, but in much smaller amounts.)

==================================================

Men on Androgen Deprivation Therapy (ADT) may be at higher risk for Alzheimer’s. Learn more... (Click to tweet)

==================================================

However, androgens can also feed prostate cancer cells, making tumors grow. The goal of androgen deprivation therapy is to either reduce androgen levels (by medication or surgery) or stop them from working (usually with medicine). These methods slow down tumor growth because prostate cancer cells have less fuel to work with.

Continued...

1 2 3 Next » (page 1 of 3)